Bain Capital Ventures, a venture capital firm, led a $45m Series B round in Loyal, a biotech company, with participation from Khosla Ventures, First Round Capital, Box Group, Collaborative Fund, Quiet Capital, Valor Equity Partners and Todd & Rahul’s Angel Fund. “This fundraise fuels our efforts to bring to market what we hope will be the first FDA-approved drug to extend healthy lifespan. All of our work is centered on giving dogs longer, healthier lives. I’m proud of the work the team has done to date and we have a very important and challenging vision to realize. I’m excited to work with our new and existing investors and continue to make FDA-approved dog longevity drugs a reality,” Celine Halioua, Loyal Founder and CEO.